Arginine-engrafted biodegradable polymer for the systemic delivery of therapeutic siRNA
- 29 February 2012
- journal article
- Published by Elsevier BV in Biomaterials
- Vol. 33 (5), 1640-1650
- https://doi.org/10.1016/j.biomaterials.2011.11.008
Abstract
No abstract availableKeywords
Funding Information
- Korea National Research Foundation (2009-0079989, 2008-2-E00772)
- Ministry of Knowledge Economy under the KORUS Tech Program (KT-2008-NT-APFS0-0001)
- WCU Program (R332009000100360)
This publication has 48 references indexed in Scilit:
- RNA interference in the clinic: challenges and future directionsNature Reviews Cancer, 2010
- Potential clinical applications of siRNA technique: benefits and limitationsEuropean Journal of Clinical Investigation, 2010
- Penetration and efficacy of VEGF siRNA using polyelectrolyte complex micelles in a human solid tumor model in-vitroJournal of Controlled Release, 2009
- Anti-tumor effects of anti-VEGF siRNA encapsulated with PLGA microspheres in miceJournal of Controlled Release, 2007
- Polymer-based siRNA delivery: Perspectives on the fundamental and phenomenological distinctions from polymer-based DNA deliveryJournal of Controlled Release, 2007
- Materializing the Potential of Small Interfering RNA via a Tumor-Targeting Nanodelivery SystemCancer Research, 2007
- siRNA-based approaches in cancer therapyCancer Gene Therapy, 2006
- DNA compaction into new DNA vectors based on cyclodextrin polymer: Surface enhanced Raman spectroscopy characterizationPeptide Science, 2005
- Lipidic Carriers of siRNA: Differences in the Formulation, Cellular Uptake, and Delivery with Plasmid DNABiochemistry, 2004
- Transport Pathways in Capillaries-In Search of PoresAnnual Review of Physiology, 1980